The author summarizes the current therapy used for lung cancer, emphasizing the diversity of opinions on the different facets of therapy for bronchogenic cancer. He then comments on his attitude towards the three forms of treatment for lung c谩ncer: surgery, radio therapy and chemotherapy, found ...
Papel del neumologo en el tratamiento del cancer de pulmon. Arch Bronconeumol 1999;35:470.Martinez Gonzalez-Rio. Papel del neumologo en el tratamiento del cancer de pulmon. Arch Bronconeumol 1999;35:470.Martinez Gonzalez-Rio J. Papel del neumologo en el tratamiento del cancer de pulmon. ...
A. SánchezC. GonzálezF. ValcárcelJ. L. ChamorroOncología (Barcelona)Provencio M, Sanchez A, Gonzalez C, Valcarcel F, Varela A, Maldonado A, et al. La PET y PET-CT en la estadificacion y tratamiento del cancer de pulmon no microcitico. Oncologia. 2007;30:100---12....
Actualización en el tratamiento sistémico del carcinoma microcítico de pulmónsmall cell lung cancersclcchemotherapyamong patients with lung cancer, the proportion of those with small cell lung cancer (sclc) type has decreased over the last decade. staging of sclc considers a limited disease and ...
Tratamiento medico- quirurgico del varicocele. Arch Esp Urol 2004; 57(9):951-61.Gonzalez Baron M (ed.). Cancer de pulmon. Annals of Oncology 1999; 8(Suppl. 1).Garcia PB, Gonzalez LJL, Diaz- Rubio GE. Cancer de Pulmon. Tiempos medicos 2006; 631: 11-22.J.de Castro Carpeo, C....
The authors contribute a series of 300 resections due to cancer of the lung, of which 160 had a follow-up superior to 3 years. They expound on the system of study and treatment used. They classify the tumors according to the T.N.M. code proposed by the American Joint Committee for C...
Resultados en el tratamiento quirurgico del cancer de pulmon no-oat cellWe have retrospectively analyzed 202 patients with UICC postsurgical stage I, II and III non-oat cell lung carcinoma. Mortality rate of 4.4% (n = 9), has been lower for the stage I (2.6%) than for the stage III (...
Carcinoma no microcitico de pulmon. Supervivencia y factores pronosticos del tratamiento radioterapico. Archivos de Bronconeumologia. 2003; 39(2): 81-6.Jaen J, Alonso A, Leon A, Rueda A. Carcinoma no microcitico de pul- mon. Supervivencia y factores pronosticos del tratamiento radioterapi- ...